A Study to Find the Genetics and Metabolism Dysfunction for Familial Partial Lipodystrophy

Overview

About this study

The purpose of this study is to find the gene mutations and metabolism dysfunctions that appear to cause the physical disorders of people who have Familial Partial Lipodystrophy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Clinical diagnosis of lipodystrophy (decreased subcutaneous fat)
  • Family history of lipodystrophy
  • Normal control subject for patients with lipodystrophy

Exclusion Criteria

  • Inability to provide informed consent
  • Hemoglobin < 10g%

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

A.J. Vinaya Simha, M.B.B.S., M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20235638

Mayo Clinic Footer